Sign in
4

Changes in Ownership

Faeth Therapeutics, Inc. Filed Acc 0001567619-22-002034

Director bought 15,000 shares at an average $4.26 ($63,849)

From the SEC's structured data for this filing

Trades in this filing

Peyer James · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-01-27 Purchase : show line 1 in the form +6,100 $4.31 $26,291 5,119,386 I
2022-01-28 Purchase : show line 2 in the form +8,900 $4.22 $37,558 5,128,286 I
Open-market purchases · 15,000 sh · avg $4.26 · $63,849
Loading xslF345X03/doc1.xml…